Keywords: Multiple Sclerosis, Multiple Sclerosis
Motivation: In multiple sclerosis (MS), fibrin(ogen) deposition is thought to be one of the earliest triggers of inflammation and demyelination in both white and gray matter of the brain.
Goal(s): To quantify fibrin(ogen) levels throughout MS disease stages and their relation to neurological impairment.
Approach: A novel molecular imaging PET probe, 64Cu-FBP8, was used to evaluate and compare fibrin(ogen) deposition levels in MS patients and healthy volunteers.
Results: Increased levels of 64Cu-FBP8 uptake compared to healthy volunteers were detected in the choroid plexus in relapsing MS and all brain regions in progressive forms. Fibrin accumulation was associated with neurological impairment.
Impact: 64Cu-FBP8 MR-PET imaging allows in vivo quantification of fibrin(ogen) levels and could aid in predicting MS disease outcomes and improve patient management strategies. Further research is needed to validate its use as a reliable biomarker in clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords